Jeff Mason is a White House Correspondent for Reuters and the 2016-2017 president of the White House Correspondents’ Association. He was the lead Reuters correspondent for President Barack Obama's 2012 campaign and interviewed the president at the White House in 2015. Jeff has been based in Washington since 2008, when he covered the historic race between Obama, Hillary Clinton and John McCain. Jeff started his career in Frankfurt, Germany, where he covered the airline industry before moving to Brussels, Belgium, where he covered the European Union. He is a Colorado native, proud graduate of Northwestern University and former Fulbright scholar.
Twitter handle: @jeffmason1
JERUSALEM There is a foul smell coming from the biblical Kidron Valley. | Video
JERUSALEM Teva Pharmaceutical Industries said it was facing accelerating price erosion in the United States, hurting he Israeli drugmaker's profits and driving down its U.S. shares more than 20 percent.
JERUSALEM Israel sent extra troops into the occupied West Bank on Saturday and its police broke up a crowd of stone-throwing Palestinians in Jerusalem as international concern mounted over the deadliest outbreak of violence between the two sides for years. | Video
TEL AVIV In the months leading up to Indian Prime Minister Narendra Modi's historic visit to Israel, India signed two arms deals, spending $2.6 billion on Israeli missile defense systems.
MISHOR ROTEM, Israel Toxic wastewater that surged through a dry riverbed in southern Israel at the weekend left a wake of ecological destruction more than 20 km (12 miles) long. | Video
HERZLIYA, Israel Israel's Navitas Petroleum plans to raise $130 million in bonds and then carry out an initial public offering (IPO) on the Tel Aviv Stock Exchange as it expands operations in the Gulf of Mexico and Canada.
TEL AVIV Teva Pharmaceutical Industries hopes to resume some production at its newly purchased Mexican plant in the coming months, but an overhaul needed to bring the factory up to speed will take a few years, the company said on Tuesday.
JERUSALEM With the ink barely dry on the $15 billion sale of his autonomous driving technology firm Mobileye to Intel , inventive Israeli entrepreneur Amnon Shashua now has his sights set on taking another start-up public by the end of next year.
JERUSALEM Teva Pharmaceutical Industries' plans to end unprofitable activities and freeze recruitment, but said Israeli media reports of up to 6,000 layoffs were incorrect.
TEL AVIV Investment bank Citi is expected to include Israel in its influential World Government Bond Index in coming months, a boost for the local bond market but a potential headache for the central bank as it fights to contain the surging shekel.